SMALL CELL LUNG CANCER ( SCLC )
Clinical trials for SMALL CELL LUNG CANCER ( SCLC ) explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CANCER ( SCLC ) trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CANCER ( SCLC ), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation drug targets cancer cells in advanced tumors
Disease control Recruiting nowThis early-phase study tests a new drug called 177Lu-RAD204 in people with advanced solid tumors (like lung, breast, or skin cancer) that have not responded to other treatments. The drug delivers a small amount of radiation directly to cancer cells by targeting a protein called P…
Matched conditions: SMALL CELL LUNG CANCER ( SCLC )
Phase: EARLY_PHASE1 • Sponsor: Radiopharm Theranostics, Ltd • Aim: Disease control
Last updated Apr 29, 2026 00:37 UTC
-
Engineered immune cells take on hard-to-treat lung cancer
Disease control Recruiting nowThis study tests a new treatment using specially designed natural killer (NK) cells to attack small cell lung cancer that has come back or not responded to standard therapy. About 60 adults aged 18-75 with advanced disease will receive these cells through an IV. The goal is to fi…
Matched conditions: SMALL CELL LUNG CANCER ( SCLC )
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Apr 29, 2026 00:35 UTC